ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Icarus.
|
261 |
64K |
4 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
64K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
Icarus.
|
159 |
50K |
9 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
159
|
50K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Icarus.
|
1.3K |
327K |
9 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.3K
|
327K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Presentation - Phase 1 Top-Line Results
|
|
Icarus.
|
34 |
10K |
23 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
34
|
10K
|
23
|
|
ASX - By Stock
|
RTR |
Re:
Rumble General
|
|
Icarus.
|
470 |
253K |
6 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
470
|
253K
|
6
|
|
ASX - By Stock
|
RTR |
Re:
Rumble General
|
|
Icarus.
|
470 |
253K |
5 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
470
|
253K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Icarus.
|
1.3K |
546K |
46 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
546K
|
46
|
|
ASX - By Stock
|
RTR |
Re:
Rumble General
|
|
Icarus.
|
470 |
253K |
2 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
470
|
253K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
post approval sp guesstimate
|
|
Icarus.
|
168 |
54K |
1 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
168
|
54K
|
1
|
|
ASX - By Stock
|
RTR |
Re:
Ann: High impact drilling commences at the Earaheedy Project
|
|
Icarus.
|
41 |
21K |
1 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
41
|
21K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
Icarus.
|
29K |
13M |
5 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
29K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Icarus.
|
10K |
3.0M |
24 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Phase III chronic lower back pain primary end point
|
|
Icarus.
|
57 |
27K |
2 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
57
|
27K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Phase III chronic lower back pain primary end point
|
|
Icarus.
|
57 |
27K |
2 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
57
|
27K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Phase III chronic lower back pain primary end point
|
|
Icarus.
|
57 |
27K |
2 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
57
|
27K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Icarus.
|
17K |
6.6M |
13 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
17K
|
6.6M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Icarus.
|
17K |
6.6M |
3 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
17K
|
6.6M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Coming News ???
|
|
Icarus.
|
510 |
221K |
41 |
05/07/20 |
05/07/20 |
ASX - By Stock
|
510
|
221K
|
41
|
|
ASX - By Stock
|
MSB |
Re:
Multisystem Inflammatory Syndrome in Children (MIS-C)
|
|
Icarus.
|
164 |
61K |
8 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
164
|
61K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Icarus.
|
17K |
6.6M |
27 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
17K
|
6.6M
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease
|
|
Icarus.
|
143 |
71K |
36 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
143
|
71K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Icarus.
|
17K |
6.6M |
26 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
17K
|
6.6M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Icarus.
|
17K |
6.6M |
30 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
17K
|
6.6M
|
30
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 ARDS and ARDS Share Price Scenarios
|
|
Icarus.
|
518 |
262K |
8 |
22/05/20 |
22/05/20 |
ASX - By Stock
|
518
|
262K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Icarus.
|
23K |
13M |
86 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
23K
|
13M
|
86
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Icarus.
|
17K |
6.6M |
68 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
17K
|
6.6M
|
68
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Icarus.
|
23K |
13M |
4 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Icarus.
|
23K |
13M |
8 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Icarus.
|
23K |
13M |
12 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
23K
|
13M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
clinicaltrials.gov - MSCs in COVID-19 ARDS
|
|
Icarus.
|
199 |
92K |
3 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
199
|
92K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
The orders are huge says NG Biotech
|
|
Icarus.
|
14 |
6.0K |
1 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
14
|
6.0K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
|
|
Icarus.
|
188 |
77K |
37 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
188
|
77K
|
37
|
|
ASX - By Stock
|
MSB |
Mesoblast vs. Athersys
|
|
Icarus.
|
5 |
3.0K |
24 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
5
|
3.0K
|
24
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: New Zone up to 19M Thick of Nickel Sulphide Mineralisation
|
|
Icarus.
|
56 |
19K |
6 |
30/07/15 |
30/07/15 |
ASX - By Stock
|
56
|
19K
|
6
|
|
ASX - By Stock
|
SI6 |
Re:
$0.011 (37.50%)
|
|
Icarus.
|
32 |
11K |
2 |
01/07/15 |
01/07/15 |
ASX - By Stock
|
32
|
11K
|
2
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: Share Purchase Plan - Revised Timetable
|
|
Icarus.
|
15 |
4.5K |
2 |
26/06/15 |
26/06/15 |
ASX - By Stock
|
15
|
4.5K
|
2
|
|
ASX - By Stock
|
SI6 |
Re:
Shell
|
|
Icarus.
|
9 |
3.8K |
2 |
13/06/15 |
13/06/15 |
ASX - By Stock
|
9
|
3.8K
|
2
|
|
ASX - By Stock
|
SI6 |
Re:
Shell
|
|
Icarus.
|
9 |
3.8K |
2 |
12/06/15 |
12/06/15 |
ASX - By Stock
|
9
|
3.8K
|
2
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: Share Purchase Plan
|
|
Icarus.
|
47 |
14K |
12 |
04/06/15 |
04/06/15 |
ASX - By Stock
|
47
|
14K
|
12
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: Significant 8200m New Drilling Commences At Maibele North
|
|
Icarus.
|
52 |
14K |
3 |
28/05/15 |
28/05/15 |
ASX - By Stock
|
52
|
14K
|
3
|
|
ASX - By Stock
|
NVA |
Re:
Ann: Details of Company Address
|
|
Icarus.
|
2 |
808 |
0 |
26/05/15 |
26/05/15 |
ASX - By Stock
|
2
|
808
|
0
|
|
ASX - By Stock
|
SI6 |
Re:
BML Timeline
|
|
Icarus.
|
55 |
22K |
5 |
12/05/15 |
12/05/15 |
ASX - By Stock
|
55
|
22K
|
5
|
|
ASX - By Stock
|
SI6 |
Re:
BML Timeline
|
|
Icarus.
|
55 |
22K |
16 |
12/05/15 |
12/05/15 |
ASX - By Stock
|
55
|
22K
|
16
|
|
ASX - By Stock
|
SI6 |
Re:
BML Timeline
|
|
Icarus.
|
55 |
22K |
1 |
08/05/15 |
08/05/15 |
ASX - By Stock
|
55
|
22K
|
1
|
|
ASX - By Stock
|
SI6 |
BML Timeline
|
|
Icarus.
|
55 |
22K |
19 |
08/05/15 |
08/05/15 |
ASX - By Stock
|
55
|
22K
|
19
|
|
ASX - By Stock
|
SI6 |
Re:
Rights Issue/Placement Closest to Pin
|
|
Icarus.
|
12 |
4.4K |
1 |
05/05/15 |
05/05/15 |
ASX - By Stock
|
12
|
4.4K
|
1
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: JOINT VENTURE CONTINUES WITH SCOPING STUDY
|
|
Icarus.
|
48 |
15K |
1 |
05/05/15 |
05/05/15 |
ASX - By Stock
|
48
|
15K
|
1
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: Quarterly Activities and Cashflow Report - 31 March 2015
|
|
Icarus.
|
20 |
7.5K |
4 |
30/04/15 |
30/04/15 |
ASX - By Stock
|
20
|
7.5K
|
4
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: JOINT VENTURE CONTINUES WITH SCOPING STUDY
|
|
Icarus.
|
48 |
15K |
1 |
30/04/15 |
30/04/15 |
ASX - By Stock
|
48
|
15K
|
1
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: JOINT VENTURE CONTINUES WITH SCOPING STUDY
|
|
Icarus.
|
48 |
15K |
9 |
29/04/15 |
29/04/15 |
ASX - By Stock
|
48
|
15K
|
9
|
|